Skip to main content
. 2020 Nov 23;34(5):1767–1781. doi: 10.1007/s40620-020-00898-8

Table 2.

Characteristics of patients eligible for NGS

Eligible cohort (n = 138)
Features Paediatric (n = 52) Adults (n = 86)
Sex
 Female n (%) 28 (53.8) 32 (37.2)
 Male n (%) 24 (46.2) 54 (62.8)
Positive family history n (%) 18 (34.6) 49 (57.0)
Age at onset mean (min–max) 3 (0–14) 37 (0–80)
Clinical suspicion
 CAKUT n (%) 3 (5.8) 0 (0)
 Tubular disease n (%) 5 (9.6) 6 (7)
 Ciliopathies n (%) 13 (25) 19 (22.1)
 Nephrolithiasis/nephrocalcinosis n (%) 1 (1.9) 1 (1.2)
 Glomerular disease n (%) 9 (17.3) 12 (13.9)
 Haemolytic uraemic syndrome n (%) 1 (1.9) 3 (3.5)
 Organ failure for unknown reasons n (%) 18 (34.6) 42 (48.8)
 Others n (%) 2 (3.9) 3 (3.5)
Genetic diagnosis
 Cases with variants identified and in line with the clinical phenotype 30 (57.7) 48 (55.8)
 Cases with no variants identified or incompatible with the clinical phenotype 22 (42.3) 38 (44.2)
CKD stage
 I 39 (75) 34 (39.6)
 II 6 (11.5) 8 (9.3)
 III 2 (3.9) 15 (17.5)
 IV 1 (1.9) 11 (12.8)
 V 0 (0) 10 (11.6)
Dialysis 0 (0) 4 (4.6)
Transplanted 4 (7.7) 4 (4.6)
Kidney biopsy performed 15 (28.8) 29 (33.7)
Imaging 41 (78.8) 69 (80.2)
Glomerular filtration rate (ml/min/1.73 m2)
 ≥ 90 39 (75) 34 (39.6)
 60–89 6 (11.5) 7 (8.1)
 30–59 2 (3.9) 16 (18.6)
 15–29 1 (1.9) 12 (13.9)
 < 15 4 (7.7) 17 (19.8)
Other characteristics
 Diabetes 0 (0) 5 (5.8)
 Hypertension 8 (15.4) 60 (69.8)
 Extra-renal features 21 (40.4) 28 (32.6)

Clinical details of the NGS-eligible study cohort (138 patients). Eligible patients are sub-divided on the basis of their gender, presence of a positive family history for kidney diseases, age at onset (mean, min and max age), clinical suspicion provided by clinicians at recruitment, results from genetic testing, chronic kidney disease (CKD) stage, availability of kidney biopsy or imaging data, glomerular filtration rate and other features. Number and percentage of cases are shown. CAKUT: congenital abnormalities of kidney and urinary tract